AI
| Followers | 843 |
| Posts | 122806 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Wednesday, April 18, 2007 5:42:55 PM
U.S. HBV market is expanding rapidly:
According to GILD (as mentioned on today’s CC), the number of U.S. HBV patients being treated with some drug has increased by 50% (from 32K to 48K) during the past 24 months because new drugs (e.g. Baraclude, Tyzeka) are expanding the market rather than merely stealing share.
Here’s a graphic representation of this (as of 11/06):
According to GILD (as mentioned on today’s CC), the number of U.S. HBV patients being treated with some drug has increased by 50% (from 32K to 48K) during the past 24 months because new drugs (e.g. Baraclude, Tyzeka) are expanding the market rather than merely stealing share.
Here’s a graphic representation of this (as of 11/06):
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
